There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection has resulted
in high rates of disease cure; however, not enough specialists currently are available
to provide care.
[1
]
From University of Maryland School of Medicine, Baltimore, Maryland; Unity Health
Care and Family and Medical Counseling Services, Washington, DC; and National Institutes
of Health, Bethesda, Maryland.